Abstract
Considerable potentiation of antiarrhythmic and antifibrilation effects of two cardiotonic agents, Suphan and the Na-channel blocker L1, was found in the model experimentsin vivo with early occlusion and reperfusion arrhythmias. Suphan in combination with L1 inhibited the rise of intracellular Ca2+ (by about 70%) in isolated cardiomyocytes incubated under hypoxic conditions.
Similar content being viewed by others
References
F. T. Ageev, D. M. Ataullakhanov, L. N. Sazonova, et al.,Ter Arkh.,57, No. 12, 52–58 (1985).
P. A. Galenko-Yaroshevskii, A. I. Khankoeva, and A. S. Dukhanin,Byull. Eksp. Biol. Med.,122, No. 7, 57–59 (1996).
D. S. Galygo,Pharmacological analysis of antiarrhythmic properties of Rikhlocaine and Leocaine [in Russian], PhD Thesis, Rostov-na-Donu (1996).
P. V. Sergeev, P. A. Galenko-Yaroshevskii, A. I. Khankoeva, and A. S. Dukhanin,Byull. Eksp. Biol. Med.,121, No. 3, 288–291 (1996).
D. G. Jullan (Ed.)Current Problems in Antiarrhythmic Therapy, London (1988).
C. L. Gibbs,Physiol. Rev.,58, 174–254 (1978).
G. Van der Vusse, R. S. Reneman,Trends Pharmacol. Sci.,6, 76–79 (1985).
Vaughan Williams E.M., in:Antiarrhythmic Drugs. Handbook of Experimental Pharmacology,89, Berlin (1989).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii I Meditsiny, Vol. 125, No. 1, pp. 59–62, January, 1998
Rights and permissions
About this article
Cite this article
Khankoeva, A.I., Dukhanin, A.S., Leonidov, N.B. et al. Antiarrhythmic properties of a new Suphan-based combined preparation and their possible mechanism of realisation. Bull Exp Biol Med 125, 50–52 (1998). https://doi.org/10.1007/BF02496800
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02496800